<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Many <z:mp ids='MP_0001799'>viral</z:mp> and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">neoplastic diseases</z:e> are resistant to interferon-alpha/beta (IFN-alpha/beta) therapy or develop resistance during the course of IFN treatment </plain></SENT>
<SENT sid="1" pm="."><plain>In patients with <z:mp ids='MP_0001799'>viral</z:mp> diseases, the authors identified four IFN inhibitors, of which the most important, most likely is a free IFN receptor of type 1 appearing in the circulation that captures and neutralizes IFN-alpha/beta </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Ninety-one <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> patients and 25 healthy individuals were studied </plain></SENT>
<SENT sid="3" pm="."><plain>Free circulating IFN receptor-alpha/beta type 1 was studied </plain></SENT>
<SENT sid="4" pm="."><plain>The patients were ages 35-75 years </plain></SENT>
<SENT sid="5" pm="."><plain>The diagnoses were 24 cases of colon <z:mp ids='MP_0002038'>carcinoma</z:mp>, 7 cases of prostate <z:mp ids='MP_0002038'>carcinoma</z:mp>, 16 cases of <z:hpo ids='HP_0003002'>breast carcinoma</z:hpo>, 8 cases of <z:mp ids='MP_0003579'>ovarian carcinoma</z:mp>, 9 cases of uterine <z:mp ids='MP_0002038'>carcinoma</z:mp>, 5 cases of <z:mp ids='MP_0008714'>lung carcinoma</z:mp>, 3 cases of <z:hpo ids='HP_0009592'>astrocytoma</z:hpo>, 4 cases of <z:hpo ids='HP_0006740'>transitional cell carcinoma of the bladder</z:hpo>, 1 case of <z:hpo ids='HP_0002669'>osteosarcoma</z:hpo>, 3 cases of <z:hpo ids='HP_0006775'>multiple myeloma</z:hpo>, 4 cases of <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">Hodgkin disease</z:e>, 2 cases of non-Hodgkin <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, 3 cases of <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo>, and 2 disseminated <z:e sem="disease" ids="C0346426" disease_type="Neoplastic Process" abbrv="">tumors of unknown origin</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: <z:hpo ids='HP_0000001'>All</z:hpo> patients were found to have increased free IFN receptor-alpha/beta type 1 in the circulation, with the highest levels reported in patients with <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: High IFN inhibitory activity in patients with <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> may be a significant factor in their increased susceptibility to progressive <z:e sem="disease" ids="C0009450" disease_type="Disease or Syndrome" abbrv="">disease, infectious</z:e> complications, and resistance to IFN therapy </plain></SENT>
<SENT sid="8" pm="."><plain>Ongoing studies are being performed with the objective of overcoming this inhibitory activity </plain></SENT>
</text></document>